날짜,공시_제목,공시자
2024-10-08,임원ㆍ주요주주특정증권등소유상황보고서,국민연금공단
2024-10-07,주식등의대량보유상황보고서(약식),국민연금공단
2024-09-02,최대주주등소유주식변동신고서              ,대웅제약
2024-08-27,최대주주등소유주식변동신고서              ,대웅제약
2024-08-27,임원ㆍ주요주주특정증권등소유상황보고서,국민연금공단
2024-08-14,반기보고서 (2024.06),대웅제약
2024-08-09,영업(잠정)실적(공정공시)              ,대웅제약
2024-08-05,투자판단관련주요경영사항              ,대웅제약
2024-07-15,타인에대한채무보증결정              ,대웅제약
2024-07-04,[기재정정]단일판매ㆍ공급계약체결              ,대웅제약
2024-06-27,지속가능경영보고서등관련사항(자율공시)              ,대웅제약
2024-06-25,투자판단관련주요경영사항              ,대웅제약
2024-05-31,기업지배구조보고서공시              ,대웅제약
2024-05-14,분기보고서 (2024.03),대웅제약
2024-04-29,영업(잠정)실적(공정공시)              ,대웅제약
2024-04-16,투자판단관련주요경영사항              ,대웅제약
2024-04-15,투자판단관련주요경영사항              ,대웅제약
2024-04-09,투자설명서,대웅제약
2024-04-09,증권발행실적보고서,대웅제약
2024-04-08,[발행조건확정]증권신고서(채무증권),대웅제약
2024-04-08,투자판단관련주요경영사항              ,대웅제약
2024-04-02,주식등의대량보유상황보고서(약식),국민연금공단
2024-03-28,최대주주등소유주식변동신고서              ,대웅제약
2024-03-28,임원ㆍ주요주주특정증권등소유상황보고서,전승호
2024-03-28,사외이사의선임ㆍ해임또는중도퇴임에관한신고,대웅제약
2024-03-28,대표이사(대표집행임원)변경(안내공시)              ,대웅제약
2024-03-28,정기주주총회결과              ,대웅제약
2024-03-21,[기재정정]신규시설투자등              ,대웅제약
2024-03-20,사업보고서 (2023.12),대웅제약
2024-03-14,[기재정정]단일판매ㆍ공급계약체결              ,대웅제약
2024-03-11,공정거래자율준수프로그램운영현황(안내공시)              ,대웅제약
2024-03-08,감사보고서제출              ,대웅제약
2024-02-27,의결권대리행사권유참고서류,대웅제약
2024-02-27,주주총회소집공고,대웅제약
2024-02-26,현금ㆍ현물배당결정              ,대웅제약
2024-02-26,주주총회소집결의              ,대웅제약
2024-02-05,영업(잠정)실적(공정공시)              ,대웅제약
2024-02-05,매출액또는손익구조30%(대규모법인은15%)이상변경              ,대웅제약
2024-02-01,[기재정정]단일판매ㆍ공급계약체결,대웅제약
2023-12-01,단일판매ㆍ공급계약체결,대웅제약
2023-11-21,기업설명회(IR)개최(안내공시),대웅제약
2023-11-14,분기보고서 (2023.09),대웅제약
2023-10-27,타법인주식및출자증권취득결정(자율공시),대웅제약
2023-10-27,영업(잠정)실적(공정공시),대웅제약
2023-10-19,임원ㆍ주요주주특정증권등소유상황보고서,대웅
2023-10-19,최대주주등소유주식변동신고서,대웅제약
2023-10-06,임원ㆍ주요주주특정증권등소유상황보고서,대웅
2023-10-06,최대주주등소유주식변동신고서,대웅제약
2023-10-05,주식등의대량보유상황보고서(약식),국민연금공단
2023-09-22,임원ㆍ주요주주특정증권등소유상황보고서,대웅
2023-09-22,최대주주등소유주식변동신고서,대웅제약
2023-09-14,최대주주등소유주식변동신고서,대웅제약
2023-09-14,임원ㆍ주요주주특정증권등소유상황보고서,대웅
2023-09-06,최대주주등소유주식변동신고서,대웅제약
2023-09-06,임원ㆍ주요주주특정증권등소유상황보고서,대웅
2023-08-29,임원ㆍ주요주주특정증권등소유상황보고서,대웅
2023-08-29,최대주주등소유주식변동신고서,대웅제약
2023-08-21,임원ㆍ주요주주특정증권등소유상황보고서,대웅
2023-08-21,최대주주등소유주식변동신고서,대웅제약
2023-08-14,반기보고서 (2023.06),대웅제약
2023-08-10,최대주주등소유주식변동신고서,대웅제약
2023-08-10,임원ㆍ주요주주특정증권등소유상황보고서,대웅
2023-07-27,영업(잠정)실적(공정공시),대웅제약
2023-07-04,주식등의대량보유상황보고서(약식),국민연금공단
2023-06-29,지속가능경영보고서등관련사항(자율공시),대웅제약
2023-06-27,투자판단관련주요경영사항,대웅제약
2023-06-05,투자판단관련주요경영사항,대웅제약
2023-05-31,기업지배구조보고서공시,대웅제약
2023-05-18,[기재정정]분기보고서 (2023.03),대웅제약
2023-05-03,영업(잠정)실적(공정공시),대웅제약
2023-05-03,기업설명회(IR)개최(안내공시),대웅제약
2023-05-02,신규시설투자등,대웅제약
2023-04-28,투자판단관련주요경영사항,대웅제약
2023-04-04,주식등의대량보유상황보고서(약식),국민연금공단
2023-03-29,사외이사의선임ㆍ해임또는중도퇴임에관한신고,대웅제약
2023-03-29,정기주주총회결과,대웅제약
2023-03-24,공정거래자율준수프로그램운영현황(안내공시),대웅제약
2023-03-21,사업보고서 (2022.12),대웅제약
2023-03-15,주식등의대량보유상황보고서(일반),대웅
2023-03-15,임원ㆍ주요주주특정증권등소유상황보고서,대웅
2023-03-15,임원ㆍ주요주주특정증권등소유상황보고서,이창재
2023-03-14,[첨부정정]의결권대리행사권유참고서류,대웅제약
2023-03-14,최대주주등소유주식변동신고서,대웅제약
2023-03-14,자기주식처분결과보고서,대웅제약
2023-03-14,주주총회소집공고,대웅제약
2023-03-13,불성실공시법인지정,유가증권시장본부
2023-03-09,임원ㆍ주요주주특정증권등소유상황보고서,국민연금공단
2023-03-09,[기재정정]주요사항보고서(자기주식처분결정),대웅제약
2023-03-08,주주총회소집결의,대웅제약
2023-03-08,감사보고서제출,대웅제약
2023-03-08,현금ㆍ현물배당결정,대웅제약
2023-02-24,단일판매ㆍ공급계약체결,대웅제약
2023-02-23,기업설명회(IR)개최(안내공시),대웅제약
2023-02-17,투자판단관련주요경영사항(<보툴리눔 균주 및 독소제제 제조기술정보의 사용금지 및 손해배상청구>에 대한 강제집행정지신청 인용),대웅제약
2023-02-15,투자판단관련주요경영사항,대웅제약
2023-02-15,소송등의제기ㆍ신청(일정금액이상의청구),대웅제약
2023-02-15,[기재정정]소송등의판결ㆍ결정(일정금액이상의청구),대웅제약
2023-02-15,영업(잠정)실적(공정공시),대웅제약
2023-02-15,매출액또는손익구조30%(대규모법인은15%)이상변경,대웅제약
2023-02-15,불성실공시법인지정예고,유가증권시장본부
2023-02-13,조회공시요구(풍문또는보도)에대한답변(미확정),대웅제약
2023-02-10,조회공시요구(풍문또는보도),유가증권시장본부
2023-01-31,투자판단관련주요경영사항(섬유증질환 치료제의 중국내 임상개발 및 상업화 권리에 관한 기술수출 계약),대웅제약
2023-01-05,임원ㆍ주요주주특정증권등소유상황보고서,국민연금공단
2022-12-09,투자판단관련주요경영사항,대웅제약
2022-12-01,투자판단관련주요경영사항(제2형 당뇨병 치료제 'DWP16001(SGLT2 저해제)' 식품의약품안전처 국내 품목허가 승인),대웅제약
2022-11-16,기업설명회(IR)개최(안내공시),대웅제약
2022-11-14,분기보고서 (2022.09),대웅제약
2022-10-31,영업(잠정)실적(공정공시),대웅제약
2022-10-07,최대주주등소유주식변동신고서,대웅제약
2022-10-06,주식등의대량보유상황보고서(약식),국민연금공단
2022-10-05,임원ㆍ주요주주특정증권등소유상황보고서,국민연금공단
2022-08-22,기업설명회(IR)개최(안내공시),대웅제약
2022-08-16,반기보고서 (2022.06),대웅제약
2022-07-28,영업(잠정)실적(공정공시),대웅제약
2022-07-15,임원ㆍ주요주주특정증권등소유상황보고서,국민연금공단
2022-07-13,임원ㆍ주요주주특정증권등소유상황보고서,국민연금공단
2022-07-13,임원ㆍ주요주주특정증권등소유상황보고서,국민연금공단
2022-07-07,임원ㆍ주요주주특정증권등소유상황보고서,국민연금공단
2022-07-07,임원ㆍ주요주주특정증권등소유상황보고서,국민연금공단
2022-07-05,주식등의대량보유상황보고서(약식),국민연금공단
2022-07-04,임원ㆍ주요주주특정증권등소유상황보고서,국민연금공단
2022-06-09,기업설명회(IR)개최(안내공시),대웅제약
2022-05-31,최대주주등소유주식변동신고서,대웅제약
2022-05-31,기업지배구조보고서공시,대웅제약
2022-05-16,분기보고서 (2022.03),대웅제약
2022-05-02,기업설명회(IR)개최(안내공시),대웅제약
2022-04-28,영업(잠정)실적(공정공시),대웅제약
2022-04-25,기타경영사항(자율공시),대웅제약
2022-04-05,주식등의대량보유상황보고서(약식),국민연금공단
2022-04-01,투자판단관련주요경영사항,대웅제약
2022-03-29,투자판단관련주요경영사항,대웅제약
2022-03-29,주식매수선택권부여에관한신고,대웅제약
2022-03-29,사외이사의선임ㆍ해임또는중도퇴임에관한신고,대웅제약
2022-03-29,정기주주총회결과,대웅제약
2022-03-24,공정거래자율준수프로그램운영현황(안내공시),대웅제약
2022-03-21,사업보고서 (2021.12),대웅제약
2022-03-18,투자판단관련주요경영사항,대웅제약
2022-03-14,주주총회소집공고,대웅제약
2022-03-14,의결권대리행사권유참고서류,대웅제약
2022-03-08,주주총회소집결의,대웅제약
2022-03-08,감사보고서제출,대웅제약
2022-03-08,현금ㆍ현물배당결정,대웅제약
2022-02-22,기업설명회(IR)개최(안내공시),대웅제약
2022-02-17,투자판단관련주요경영사항,대웅제약
2022-02-16,기업설명회(IR)개최(안내공시),대웅제약
2022-02-15,매출액또는손익구조30%(대규모법인은15%)이상변경,대웅제약
2022-02-15,영업(잠정)실적(공정공시),대웅제약
2022-01-14,투자판단관련주요경영사항,대웅제약
2022-01-14,투자판단관련주요경영사항,대웅제약
2022-01-05,주식등의대량보유상황보고서(약식),국민연금공단
2022-01-03,대표이사(대표집행임원)변경(안내공시),대웅제약
2021-12-31,투자판단관련주요경영사항,대웅제약
2021-12-30,투자판단관련주요경영사항,대웅제약
2021-12-08,투자판단관련주요경영사항,대웅제약
2021-11-17,기업설명회(IR)개최(안내공시),대웅제약
2021-11-15,분기보고서 (2021.09),대웅제약
2021-11-01,기업설명회(IR)개최(안내공시),대웅제약
2021-10-27,영업(잠정)실적(공정공시),대웅제약
2021-10-15,단일판매ㆍ공급계약체결,대웅제약
2021-08-17,반기보고서 (2021.06),대웅제약
2021-08-17,[기재정정]분기보고서 (2021.03),대웅제약
2021-08-17,[기재정정]사업보고서 (2020.12),대웅제약
2021-08-09,기업설명회(IR)개최(안내공시),대웅제약
2021-07-29,영업(잠정)실적(공정공시),대웅제약
2021-07-22,증권발행실적보고서,대웅제약
2021-07-22,투자설명서,대웅제약
2021-07-21,[발행조건확정]증권신고서(채무증권),대웅제약
2021-07-02,주식등의대량보유상황보고서(약식),국민연금공단
2021-06-08,투자판단관련주요경영사항(펙수프라잔(Fexuprazan) 기술이전(Licensing Out) 계약 체결),대웅제약
2021-05-18,기업설명회(IR)개최(안내공시),대웅제약
2021-05-06,영업(잠정)실적(공정공시),대웅제약
2021-03-29,사외이사의선임ㆍ해임또는중도퇴임에관한신고,대웅제약
2021-03-26,정기주주총회결과,대웅제약
2021-03-26,주식매수선택권부여에관한신고,대웅제약
2021-03-26,타법인주식및출자증권취득결정,대웅제약
2021-03-24,투자판단관련주요경영사항,대웅제약
2021-03-23,주식등의대량보유상황보고서(일반),대웅
2021-03-22,자기주식처분결과보고서,대웅제약
2021-03-22,임원ㆍ주요주주특정증권등소유상황보고서,대웅
2021-03-22,최대주주등소유주식변동신고서,대웅제약
2021-03-18,주요사항보고서(자기주식처분결정),대웅제약
2021-03-11,의결권대리행사권유참고서류,대웅제약
2021-03-11,주주총회소집공고,대웅제약
2021-03-11,주주총회집중일개최사유신고,대웅제약
2021-03-11,주주총회소집결의,대웅제약
2021-03-11,현금ㆍ현물배당결정,대웅제약
2021-03-11,감사보고서제출,대웅제약
2021-02-22,공정거래자율준수프로그램운영현황(안내공시),대웅제약
2021-02-15,매출액또는손익구조30%(대규모법인은15%)이상변경,대웅제약
2021-02-15,영업(잠정)실적(공정공시),대웅제약
2021-01-25,투자판단관련주요경영사항(코로나치료제 DWJ1248의 COVID-19 예방 목적 임상3상 시험계획 승인),대웅제약
2021-01-05,주식등의대량보유상황보고서(약식),국민연금공단
2021-01-04,투자판단관련주요경영사항,대웅제약
2020-12-30,투자판단관련주요경영사항(위식도역류질환치료제 '펙수프라잔'의 중국 1/3상 임상시험계획 승인 ),대웅제약
2020-12-17,기타경영사항(자율공시),대웅제약
2020-12-17,투자판단관련주요경영사항,대웅제약
2020-11-23,최대주주등소유주식변동신고서,대웅제약
2020-11-23,임원ㆍ주요주주특정증권등소유상황보고서,전승호
2020-11-16,분기보고서 (2020.09),대웅제약
2020-11-04,영업(잠정)실적(공정공시),대웅제약
2020-10-21,투자판단관련주요경영사항,대웅제약
2020-10-06,주식등의대량보유상황보고서(약식),국민연금공단
2020-08-14,반기보고서 (2020.06),대웅제약
2020-08-14,단일판매ㆍ공급계약체결,대웅제약
2020-07-30,영업(잠정)실적(공정공시),대웅제약
2020-07-22,단기차입금증가결정(자율공시),대웅제약
2020-07-07,주권관련사채권의취득결정,대웅제약
2020-07-07,기타경영사항(자율공시),대웅제약
2020-07-03,주식등의대량보유상황보고서(약식),국민연금공단
2020-05-15,분기보고서 (2020.03),대웅제약
2020-05-07,영업(잠정)실적(공정공시),대웅제약
2020-04-03,주식등의대량보유상황보고서(약식),국민연금공단
2020-03-30,사업보고서 (2019.12),대웅제약
2020-03-25,자기주식처분결과보고서,대웅제약
2020-03-25,주식등의대량보유상황보고서(일반),대웅
2020-03-25,임원ㆍ주요주주특정증권등소유상황보고서,대웅
2020-03-25,최대주주등소유주식변동신고서,대웅제약
2020-03-24,주식등의대량보유상황보고서(일반),대웅
2020-03-24,임원ㆍ주요주주특정증권등소유상황보고서,김홍철
2020-03-23,타법인주식및출자증권취득결정(자율공시),대웅제약
2020-03-23,주요사항보고서(자기주식처분결정),대웅제약
2020-03-23,최대주주등소유주식변동신고서,대웅제약
2020-03-20,정기주주총회결과,대웅제약
2020-03-09,주식등의대량보유상황보고서(일반),대웅
2020-03-09,[기재정정]의결권대리행사권유참고서류,대웅제약
2020-03-06,임원ㆍ주요주주특정증권등소유상황보고서,전승호
2020-03-05,주주총회소집공고,대웅제약
2020-03-05,주주총회집중일개최사유신고,대웅제약
2020-03-05,최대주주등소유주식변동신고서,대웅제약
2020-03-05,감사보고서제출,대웅제약
2020-02-27,현금ㆍ현물배당결정,대웅제약
2020-02-27,주주총회소집결의,대웅제약
2020-02-19,매출액또는손익구조30%(대규모법인은15%)이상변경,대웅제약
2020-02-13,영업(잠정)실적(공정공시),대웅제약
2020-02-05,공정거래자율준수프로그램운영현황(안내공시),대웅제약
2019-11-14,분기보고서 (2019.09),대웅제약
2019-11-01,영업(잠정)실적(공정공시),대웅제약
2019-10-31,기업설명회(IR)개최(안내공시),대웅제약
2019-10-30,증권발행실적보고서,대웅제약
2019-10-30,투자설명서,대웅제약
2019-10-29,[발행조건확정]증권신고서(채무증권),대웅제약
2019-09-03,기업설명회(IR)개최(안내공시),대웅제약
2019-08-14,반기보고서 (2019.06),대웅제약
2019-07-31,영업(잠정)실적(공정공시),대웅제약
2019-06-27,임원ㆍ주요주주특정증권등소유상황보고서,대웅
2019-06-27,최대주주등소유주식변동신고서,대웅제약
2019-06-05,기업설명회(IR)개최(안내공시),대웅제약
2019-05-31,임원ㆍ주요주주특정증권등소유상황보고서,대웅
2019-05-31,최대주주등소유주식변동신고서,대웅제약
2019-05-28,최대주주등소유주식변동신고서,대웅제약
2019-05-23,임원ㆍ주요주주특정증권등소유상황보고서,대웅
2019-05-23,최대주주등소유주식변동신고서,대웅제약
2019-05-17,임원ㆍ주요주주특정증권등소유상황보고서,대웅
2019-05-17,최대주주등소유주식변동신고서,대웅제약
2019-05-15,최대주주등소유주식변동신고서,대웅제약
2019-05-15,분기보고서 (2019.03),대웅제약
2019-05-14,기업설명회(IR)개최(안내공시),대웅제약
2019-04-30,영업(잠정)실적(공정공시),대웅제약
2019-04-25,투자설명서,대웅제약
2019-04-25,증권발행실적보고서,대웅제약
2019-04-24,[발행조건확정]증권신고서(채무증권),대웅제약
2019-04-11,기업설명회(IR)개최(안내공시),대웅제약
2019-04-02,주식등의대량보유상황보고서(약식),국민연금공단
2019-04-01,사업보고서 (2018.12),대웅제약
2019-03-22,정기주주총회결과,대웅제약
2019-03-07,감사보고서제출,대웅제약
2019-03-07,주주총회소집공고,대웅제약
2019-03-06,현금ㆍ현물배당결정,대웅제약
2019-03-06,[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변경,대웅제약
2019-03-06,주식매수선택권부여에관한신고,대웅제약
2019-03-06,주주총회소집결의,대웅제약
2019-03-06,주주총회집중일개최사유신고,대웅제약
2019-03-05,영업(잠정)실적(공정공시),대웅제약
2019-02-21,기업설명회(IR)개최(안내공시),대웅제약
2019-02-07,투자판단관련주요경영사항,대웅제약
2019-01-29,공정거래자율준수프로그램운영현황(안내공시),대웅제약
